{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "9099470",
  "DateCompleted": {
    "Year": "1997",
    "Month": "06",
    "Day": "18"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "09",
    "Day": "14"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0362-5664",
      "JournalIssue": {
        "Volume": "20",
        "Issue": "2",
        "PubDate": {
          "Year": "1997",
          "Month": "Apr"
        }
      },
      "Title": "Clinical neuropharmacology",
      "ISOAbbreviation": "Clin Neuropharmacol"
    },
    "ArticleTitle": "Spiking fevers with clozapine treatment.",
    "Pagination": {
      "StartPage": "168",
      "EndPage": "170",
      "MedlinePgn": "168-70"
    },
    "Abstract": {
      "AbstractText": [
        "Clozapine often causes low-grade fever and less frequently spiking fever. We describe three cases of spiking fever that occurred in the first 3 weeks of clozapine therapy. A new set of side effects of clozapine is identified, which includes spiking fever, respiratory and gastrointestinal symptoms, and neutrophilia. Possible mechanisms are discussed."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Clinical Psychobiology, New York State Psychiatric Institute, New York 10032, USA."
          }
        ],
        "LastName": "Tr\u00e9meau",
        "ForeName": "F",
        "Initials": "F"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Clark",
        "ForeName": "S C",
        "Initials": "SC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Printz",
        "ForeName": "D",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kegeles",
        "ForeName": "L S",
        "Initials": "LS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Malaspina",
        "ForeName": "D",
        "Initials": "D"
      }
    ],
    "PublicationTypeList": [
      "Case Reports",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Clin Neuropharmacol",
    "NlmUniqueID": "7607910",
    "ISSNLinking": "0362-5664"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antipsychotic Agents"
    },
    {
      "RegistryNumber": "J60AR2IKIC",
      "NameOfSubstance": "Clozapine"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Antipsychotic Agents"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Clozapine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "chemically induced"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [
        "chemically induced"
      ],
      "DescriptorName": "Gastrointestinal Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Leukocyte Count"
    },
    {
      "QualifierName": [
        "chemically induced"
      ],
      "DescriptorName": "Lung Diseases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Neutrophils"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Psychotic Disorders"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Schizophrenia, Paranoid"
    }
  ]
}